Search

everythinglearnresearchcommunity

for

Search:↓

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Immune cells affect hair growth and could lead to new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.